New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 19, 2014
12:20 EDTCVS, RAD, WAG, MCKRite Aid slides after posting a steeper decline in profit vs. last year
Shares of retail drugstore chain Rite Aid (RAD) are falling after the company reported that its first quarter profit was down significantly from the year-ago period. WHAT'S NEW: Rite Aid reported Q1 earnings per share of 4c, matching analyst's expectations, but below the 9c it reported last year. Revenue for the quarter was $6.47B, slightly higher than expectations of $6.43B ad $6.3B in the prior year quarter. Rite Aid's Q1 same-store sales were up 3.1% over the prior year period. The retailer reported net income of $41.4M, well below the company's net income at this time last year of $89.7M. A decrease in adjusted EBITDA and higher income tax expense contributed to this result and these factors were partially offset by lower interest expense and a lower LIFO charge. Rite Aid confirmed that it sees fiscal year 2015 EPS in the range of 30c-40c, while analysts estimate that EPS will be 35c. The company still sees FY15 revenue to be between $26B-$26.5B, which is in line with analyst's consensus of $26.19B. The retailer confirmed that it sees FY15 SSS of up to 2.5%-4.5% vs. fiscal year 2014. WHAT'S NOTABLE: During the company's Q1 earnings conference call, Rite Aid said that as it more aggressively pursues opportunities for growth, it is prepared to increase allocation for prescription file buys if additional opportunities arise throughout the fiscal year. The retailer expects the current competitive environment to remain promotional and is also considering plan wages and benefit increases. Rite Aid said that it increased its expected working capital benefit to $250M from $150M as a result of the McKesson (MCK) agreement and says the working capital benefit will not be fully realized until the fourth quarter. As the company mentioned on its FY14 earnings call in April, it expected the second half of FY15 to be stronger than the first two quarters due in part to the strength of FY14's first half as well as the introduction of new generics in 2H15. Rite Aid anticipates closing a total of 40 stores of which the guidance includes a store lease closing provision for FY15 to balance closing upon lease expiration. ANALYST REACTION: UBS analyst Scott Arwin said that generic drug MAC-ing by pharmacy benefit managers was a component in Rite Aid's Q1 earnings falling below predictions. He said that the retailer's management suggested that historically, they would usually have some ability to go back to generic manufacturers to offset some of the MAC reimbursement cuts. In this situation, however, Arwin said the company is currently hindered temporarily on their ability to do this during the transition of its generic procurement over to McKesson. Ride Aid suggested that this will also impact second quarter results as well, Arwin said. UBS maintains its Neutral rating on the drugstore franchise and raised its price target to $7.50 from $7.00. PRICE ACTION: During afternoon trading, Rite Aid was down 24c or 3.23%, to $7.20. OTHERS TO WATCH: Rite Aid peer Walgreen Company (WAG) was down around 0.8% to $75.45, while CVS Caremark (CVS) was up moderately to $77.46.
News For RAD;MCK;WAG;CVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 27, 2015
16:01 EDTRADOptions Update; March 27, 2015
iPath S&P 500 VIX Short-Term Futures down 31c to 25.74 Option volume leaders: AAPL TSLA TWTR RAD FB PBR AMZN DOW VLO AMAT ALTR according to Track Data.
14:08 EDTRADRite Aid calls active as shares approach high
Subscribe for More Information
06:00 EDTRADRite Aid implied volatility of 65 at upper end of index
March 26, 2015
06:00 EDTRADRite Aid implied volatility of 64 at upper end of index
Subscribe for More Information
March 25, 2015
16:37 EDTCVSSpecialists On Call names Hammad Shah as CEO
Subscribe for More Information
11:45 EDTMCK, CVSLeerink healthcare tech/pharma analysts hold analyst/industry conference call
Subscribe for More Information
March 24, 2015
10:22 EDTRADRite Aid is ripe for a buyout, says Detwiler Fenton
Subscribe for More Information
March 23, 2015
11:26 EDTRADStocks with call strike movement; VALE RAD
Subscribe for More Information
06:07 EDTRADRite Aid implied volatility of 61 at upper end of index
March 20, 2015
06:09 EDTRADRite Aid implied volatility of 63 at upper end of index
March 19, 2015
16:01 EDTRADOptions Update; March 19, 2015
Subscribe for More Information
11:02 EDTRADOptions with increasing implied volatility
Options with increasing implied volatility: HLF RAD NFLX HLSS NOW
09:37 EDTRADActive equity options trading on open
Subscribe for More Information
07:04 EDTRADAmerican Express confirms plans to launch Plenti loyalty program
Subscribe for More Information
05:49 EDTRADStocks with implied volatility movement; RAD XLV
Subscribe for More Information
March 18, 2015
16:00 EDTRADOptions Update; March 18, 2015
iPath S&P 500 VIX Short-Term Futures down 1.20 to 26.10. Option volume leaders: AAPL RAD PBR TWTR FB TSLA CLF BP MGM according to Track Data.
10:30 EDTRADRite Aid calls active on renewed takeover speculation
Rite Aid April 8 and 9 calls are active on 138K contracts (1K puts) on renewed takeover speculation. March call option implied volatility is at 72, April is at 62, May is at 53; compared to its 26-week average of 44 according to Track Data. Active call volume suggests traders taking positions for larger near term price movement.
10:15 EDTRADRumor: Rite Aid moves higher on renewed takeover speculation
Subscribe for More Information
06:16 EDTRADAmerican Express to launch Plenti loyalty program this spring, WSJ reports
Subscribe for More Information
March 17, 2015
06:31 EDTCVSStudies find Gilead's hepatitis C drugs cost effective, Reuters says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use